Abstract:OBJECTIVE: The aim of the study was to elucidate the long-term outcomes of atrial fibrillation surgery in patients with atrial fibrillation and mitral valve disease by comparing the patients who underwent mitral valve surgery with and without atrial fibrillation surgery.METHODS: Between 2005 and 2017, 2680 patients with atrial fibrillation who underwent mitral valve surgery (mitral valve surgery with atrial fibrillation surgery, n = 1841; mitral valve surgery without atrial fibrillation surgery, n = 839) at 5 centers were included. After propensity score matching, 1442 patients were extracted (atrial fibrillation surgery group, n = 721; non-atrial fibrillation surgery group, n = 721). All-cause mortality, cardiac mortality, major adverse cardiac and cerebrovascular events, stroke or transient ischemic attack, and permanent pacemaker implantation were compared between the atrial fibrillation surgery and non-atrial fibrillation surgery groups.RESULTS: Overall survivals at 5 and 10 years postoperatively were 91.0% and 80.7% in the atrial fibrillation surgery group and 86.5% and 75.9% in the non-atrial fibrillation surgery group, respectively (P = .013). Cardiac mortality-free survivals at 5 and 10 years postoperatively were 96.9% and 91.7% in the atrial fibrillation surgery group and 90.9% and 83.7% in the non-atrial fibrillation surgery group, respectively (P < .001). Cumulative incidence of reoperation, major adverse cardiac and cerebrovascular events, and stroke or transient ischemic attack was lower in the matched atrial fibrillation surgery group compared with the matched non-atrial fibrillation surgery group up to 15 years postoperatively (P = .010, P < .001, and P = .012, respectively). Cumulative incidence of permanent pacemaker implantation was higher in the matched atrial fibrillation surgery group compared with the matched non-atrial fibrillation surgery group (P < .001).CONCLUSIONS: In patients with atrial fibrillation and mitral valve disease, mitral valve surgery concomitant with atrial fibrillation surgery was associated with lower mortality, cardiac mortality, major adverse cardiac and cerebrovascular events, and stroke or transient ischemic attack up to 15 years after surgery when compared with mitral valve surgery without atrial fibrillation surgery.

Concomitant treatment of atrial fibrillation during mitral valve surgery

Concomitant Surgical Ablation in Paroxysmal vs Persistent Atrial Fibrillation During Mitral Surgery

Surgical ablation of atrial fibrillation during mitral valve surgery: a systematic review and meta-analysis

The outcomes of concomitant catheter ablation in non-mitral valve cardiac surgery—a systematic review and meta-analysis of the literature

Concomitant atrial fibrillation ablation in minimally invasive cardiac surgery

Long-term efficacy of concomitant surgical ablation for atrial fibrillation with cardiac surgery

Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials

Surgical options for atrial fibrillation treatment during concomitant cardiac procedures

Concomitant Surgical Ablation for Treatment of Atrial Fibrillation in Patients Undergoing Minimally Invasive Mitral Valve Surgery: A Single-Center Experience in Vietnam

Treating Atrial Fibrillation Is No MAZE: A Reminder To Heart Teams For Concomitant Surgical Ablation For Atrial Fibrillation With Cardiac Surgery

Incidence, etiology, and outcomes of pre- and post-operative atrial fibrillation in mitral valve procedures: a review

Long-term results of atrial fibrillation surgery concomitant with mitral valve surgery: A propensity score–matched multicenter study

Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†

Concomitant interventions in mitral valve surgery – A European perspective

Hybrid strategies for stand-alone surgical ablation of atrial fibrillation

Surgical strategy for atrial functional mitral regurgitation with atrial fibrillation

Surgical Ablation for Atrial Fibrillation in Mitral Valve Surgery: Improved Survival and Stroke Risk in US Veterans

Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic Valve Disease

Mitral Valve Repair and Surgical Ablation for Atrial Functional Mitral Regurgitation

Current status of the surgical treatment of atrial fibrillation

Catheter Ablation or Surgical Therapy in Severe Atrial Functional Mitral Regurgitation Caused by Long‐Standing Persistent Atrial Fibrillation—Propensity Score Analysis